Creabilis SA: Clinical Trials

7 trials sponsored by Creabilis SA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 13Completed 2, Withdrawn 1

Follow Creabilis SA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
CT327 ointment, placebo - Atopic Dermatitis
Phase 2CompletedCreabilis SA1882013-07-012015-11-25
Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris
CT327 0.05%, CT327 0.1%, CT327 0.5% - Psoriasis Vulgaris
Phase 2CompletedCreabilis SA1602011-12-012013-03-08
A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers
CT327 (or placebo) followed by placebo (or CT327) - Neuropathic Pain
Phase 1CompletedCreabilis SA242011-01-012011-06-08
CT 327 in the Treatment of Psoriasis Vulgaris
placebo, CT 327 - Psoriasis
Phase 2CompletedCreabilis SA582010-03-012011-02-10
CT 327 in the Treatment of Atopic Dermatitis
placebo, CT 327 - Mild to Moderate Atopic Dermatitis
Phase 2TerminatedCreabilis SA152009-11-012010-10-26
A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers
0.01% CT327 (or placebo), 0.001% CT327 (or placebo) - Safety
Phase 1CompletedCreabilis SA162007-09-012010-11-18
CT 327 in the "Atopy Patch Test" Model
CT327 application, Placebo, Active comparator - Atopic Dermatitis
Phase 1WithdrawnCreabilis SA202011-06-07

Conditions studied

Dermatitis, Atopic (2)  ·  Neuralgia (1)  ·  Pruritus (1)  ·  Psoriasis (1)

Interventions

pegcantratinib (2)

Countries

United Kingdom (3)  ·  Switzerland (2)  ·  United States (2)  ·  Denmark (1)  ·  Germany (1)

Top investigators

Prof. Dr. Med. Johannes Ring (1)